Stay updated with breaking news from Entrega Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1 launch of two new Founded Entities,2 including a $100 million Series A financing for...
Strong strategic and clinical progress in 2023, with multiple catalysts expected in 2024 Launching of two new Founded Entities to advance certain programs from the Wholly Owned Pipeline Robust...
PureTech Announces Annual Results for Year Ended December 31, 2021 - read this article along with other careers information, tips and advice on BioSpace
Investegate announcements from PureTech Health PLC, PRTC Provides Recap Ahead of Catalyst-Rich 2022
PureTech Announces Annual Results for Year Ended December 31, 2020 By Staff 2 seconds ago Strong capital base and cash runway extended into the first quarter of 2025, with PureTech level cash and cash equivalents of $443.4 million as of March 31, 2021 1 ($349.4 million as of December 31, 2020 2) and consolidated cash and cash equivalents of $486.5 million as of March 31, 2021 3 ($403.9 million as of December 31, 2020 4) Advancement of Wholly Owned Pipeline with four clinical trial initiations and one successful readout, with three clinical trials ongoing Significant milestones across PureT...